LINC02700

Across TCGA pan-cancer cohorts, LINC02700 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC02700’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC02700 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02700 is over-expressed in tumor, although a few such as BRCA and LUAD show the opposite, repressed pattern.

STAD, HNSC, and BLCA are the cancer types where LINC02700 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02700 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	IV	+1.183	<.001	10	view →
HNSC	All	All	+0.729	<.001	10	view →
BLCA	All	All	+0.502	.021	3	view →
COAD	All	All	+0.151	.004	3	view →
BRCA	Female	All	−0.055	.017	2	view →
LUAD	Female	All	−0.194	.001	1	view →
KICH	All	All	−0.056	.029	1	view →
KIRC	All	All	+0.033	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC02700–STAD

Open the STAD breakdown →